Ambagon Therapeutics
Ali Tavassoli, Ph.D., is Professor of Chemical Biology at the University of Southampton and Chief Scientific Officer of Curve Therapeutics. Ali’s research is focused on the development of high throughput screening platforms that enable the discovery of protein-protein interaction inhibitors, and the conversion of cyclic peptide hits into novel therapeutics.
This person is not in the org chart
This person is not in any offices
Ambagon Therapeutics
Ambagon is discovering and developing small molecule cancer drugs that stabilize the direct interaction of oncogenic proteins with the 14-3-3 class of adaptor proteins.